These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29934071)

  • 1. Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin-intermediate Staphylococcus aureus clinical isolates.
    Truelson KA; Brennan-Krohn T; Smith KP; Kirby JE
    Diagn Microbiol Infect Dis; 2018 Oct; 92(2):168-171. PubMed ID: 29934071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kang AD; Smith KP; Eliopoulos GM; Berg AH; McCoy C; Kirby JE
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):188-191. PubMed ID: 28341099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae.
    Riedel S; Vijayakumar D; Berg G; Kang AD; Smith KP; Kirby JE
    J Antimicrob Chemother; 2019 May; 74(5):1311-1316. PubMed ID: 30689929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae.
    Smith KP; Kirby JE
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):439-441. PubMed ID: 27745736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
    Ghahremani M; Jazani NH; Sharifi Y
    J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility.
    Howe RA; Wootton M; Bennett PM; MacGowan AP; Walsh TR
    J Clin Microbiol; 1999 Sep; 37(9):3068-71. PubMed ID: 10449511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal of Epidemiological Cutoff Values for Apramycin 15 μg and Florfenicol 30 μg Disks Applicable to
    Costa SS; Ferreira C; Ribeiro R; Feßler AT; Schink AK; Kadlec K; Kaspar H; Amaro A; Albuquerque T; Abrantes P; Morais C; Pomba C; Schwarz S; Couto I
    Microb Drug Resist; 2021 Nov; 27(11):1555-1559. PubMed ID: 33956523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative.
    Bobin-Dubreux S; Reverdy ME; Nervi C; Rougier M; Bolmström A; Vandenesch F; Etienne J
    Antimicrob Agents Chemother; 2001 Jan; 45(1):349-52. PubMed ID: 11120996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility and phage typing of methicillin-resistant and -sensitive Staphylococcus aureus clinical isolates at three periods during 1991-1997.
    Samra Z; Gadba R; Ofir O
    Eur J Clin Microbiol Infect Dis; 2001 Jun; 20(6):425-7. PubMed ID: 11476446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
    Torun MM; Bahar H; Demirci M; Altaş K; Bağdatli Y; Kocazeybek B; Kapi M; Hiramatsu K
    Int J Antimicrob Agents; 2005 Dec; 26(6):508-10. PubMed ID: 16256313
    [No Abstract]   [Full Text] [Related]  

  • 12. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
    Tascini C; Flammini S; Leonildi A; Ciullo I; Tagliaferri E; Menichetti F
    J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey.
    Tekin A; Dal T; Deveci Ö; Tekin R; Özcan N; Atmaca S; Dayan S
    Braz J Microbiol; 2014; 45(3):829-33. PubMed ID: 25477914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
    J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ceftobiprole on 440 Staphylococcus aureus strains isolated from bronchopulmonary infections.
    Hodille E; Delouere L; Bouveyron C; Meugnier H; Bes M; Tristan A; Laurent F; Vandenesch F; Lina G; Dumitrescu O
    Med Mal Infect; 2017 Mar; 47(2):152-157. PubMed ID: 27856079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States.
    Mendes RE; Sader HS; Flamm RK; Farrell DJ; Jones RN
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1811-4. PubMed ID: 25561335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.